Citadel Advisors
CLOV icon

Citadel Advisors’s Clover Health Investments CLOV Stock Holding History

Citadel Advisors’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.37M Buy
1,025,400
+565,000
+123% +$1.92M ﹤0.01% 4594
2026
Q1 		$810K Sell
460,400
-97,200
-17% -$211K ﹤0.01% 8156
2025
Q4 		$1.31M Sell
557,600
-482,700
-46% -$1.32M ﹤0.01% 6813
2025
Q3 		$3.18M Buy
1,040,300
+157,200
+18% +$449K ﹤0.01% 5202
2025
Q2 		$2.46M Buy
883,100
+371,700
+73% +$1.22M ﹤0.01% 5332
2025
Q1 		$1.84M Sell
511,400
-235,900
-32% -$947K ﹤0.01% 5695
2024
Q4 		$2.35M Sell
747,300
-377,400
-34% -$1.35M ﹤0.01% 5296
2024
Q3 		$3.17M Buy
1,124,700
+746,200
+197% +$1.71M ﹤0.01% 4689
2024
Q2 		$466K Buy
378,500
+175,100
+86% +$157K ﹤0.01% 8196
2024
Q1 		$162K Sell
203,400
-204,600
-50% -$186K ﹤0.01% 10650
2023
Q4 		$388K Sell
408,000
-49,100
-11% -$48.2K ﹤0.01% 8629
2023
Q3 		$494K Buy
457,100
+120,800
+36% +$144K ﹤0.01% 8088
2023
Q2 		$302K Sell
336,300
-57,600
-15% -$51.1K ﹤0.01% 9038
2023
Q1 		$333K Sell
393,900
-766,600
-66% -$839K ﹤0.01% 9168
2022
Q4 		$1.08M Buy
1,160,500
+623,700
+116% +$832K ﹤0.01% 6669
2022
Q3 		$913K Buy
536,800
+113,400
+27% +$297K ﹤0.01% 7195
2022
Q2 		$906K Sell
423,400
-97,500
-19% -$259K ﹤0.01% 7237
2022
Q1 		$1.85M Sell
520,900
-341,000
-40% -$989K ﹤0.01% 6257
2021
Q4 		$3.21M Sell
861,900
-1,189,500
-58% -$7.3M ﹤0.01% 5201
2021
Q3 		$15.2M Sell
2,051,400
-288,800
-12% -$2.47M ﹤0.01% 2416
2021
Q2 		$31.2M Buy
2,340,200
+1,418,200
+154% +$13.9M 0.01% 1571
2021
Q1 		$6.97M Buy
922,000
+393,300
+74% +$4.44M ﹤0.01% 3592
2020
Q4 		$8.87M Buy
+528,700
New +$5.89M ﹤0.01% 2814

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors's CLOV Position: Q2 2026 in Review

Citadel Advisors increased its Clover Health Investments (CLOV) stake by 15% in Q2 2026, buying an estimated $968K and bringing the position to 2,163,205 shares worth $11.3M. The position accounts for ﹤0.01% of the portfolio, ranked #3381.

Citadel Advisors first reported a position in CLOV in Q4 2020 and has held it in 23 quarters since. The position peaked at $13.4M in Q4 2021. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Citadel Advisors held 2,163,205 shares of Clover Health Investments worth $11.3M as of Q2 2026.
  • Citadel Advisors bought 285,157 Clover Health Investments shares in Q2 2026, an estimated $968K.
  • Clover Health Investments made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #3381 holding.
  • Citadel Advisors first reported a position in Clover Health Investments in Q4 2020 and has held it in 23 quarters since.
  • Citadel Advisors's Clover Health Investments position peaked at $13.4M in Q4 2021.
  • 226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.